Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

MetLife (MET) Q2 Earnings And Revenues Miss; Decline Y/Y

Published 08/03/2016, 10:57 PM
Updated 07/09/2023, 06:31 AM
CI
-
MET
-
AIG
-
CNO
-

MetLife, Inc.’s (NYSE:MET) second-quarter 2016 earnings of 83 cents per share missed the Zacks Consensus Estimate of $1.36 by 39%. Earnings also plunged 47% year over year.

During the second quarter, MetLife generated revenues of $16.95 billion. The top line lagged the Zacks Consensus Estimate of $17.07 billion by 0.4% and also declined 2.4% year over year.

MetLife’s premiums, fees and other revenues slipped 1% year over year. Operating premiums, fees & other revenues also dipped 1%.

During the reported quarter, MetLife’s total operating expenses increased 4.5% year over year to $15.7 billion.

Segment Details

Americas

Operating earnings in this segment declined 42% (or 41% on constant currency basis) year over year to $835 million due to reserve adjustments resulting from modeling improvements in the reserving process and the annual variable annuity actuarial assumption review.

In the reported quarter, operating return on allocated equity was 8.6%, operating return on allocated tangible equity was 9.6% and operating premiums, fees & other revenues grew 1% (or 3% on a constant currency basis) to $9.3 billion.

Asia

Operating earnings were down 39% (or 41% on constant currency basis) year over year to $259 million. This was primarily due to unfavorable tax-related adjustments in Japan, reinsurance receivables adjustment in Australia and lower fixed annuity surrenders.

In the reported quarter, operating return on allocated equity was 9.4%, while operating return on allocated tangible equity was 16.2%. Operating premiums, fees & other revenues in Asia declined 8% (or 13% on a constant currency basis) to $2.1 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Total sales for the region decreased 3% on a constant currency basis due to the impact of management actions to enhance value in targeted markets.

EMEA

Operating earnings from EMEA increased 28% (or 36% on constant currency basis) year over year to $64 million.

In the reported quarter, operating return on allocated equity was 7.9%, while operating return on allocated tangible equity was 13.8%. Operating premiums, fees & other revenues were down 4% (or 1% on a constant currency basis) to $633 million.

Moreover, total sales jumped 10% on a constant currency basis. Growth in employee benefits in the Middle East as well as accident and health products across the region drove the upside.

Also, Corporate & Other operating loss was $234 million, substantially wider than the loss of $153 million in the year-ago quarter.

Investment & Financial Update

In the reported quarter, net investment income slipped 6% year over year to $4.9 billion. Variable investment income was $285 million, down 33.2% from $427 million in the prior-year quarter, mainly due to lower alternative investment income.

Zacks Rank

Currently, MetLife carries a Zacks Rank #4 (Sell).

METLIFE INC Price, Consensus and EPS Surprise

METLIFE INC Price, Consensus and EPS Surprise | METLIFE INC Quote

Performance of Other Multi Line Insurers

Among other multi line insurers that have reported their second-quarter results so far, the bottom line at CNO Financial Group Inc. (NYSE:CNO) and American International Group Inc. (NYSE:AIG) beat the respective Zack Consensus Estimate, while Cigna Corp.’s (NYSE:CI) earnings missed the same.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


AMER INTL GRP (AIG): Free Stock Analysis Report

METLIFE INC (MET): Free Stock Analysis Report

CIGNA CORP (CI): Free Stock Analysis Report

CNO FINL GRP (CNO): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.